Recent studies show on one hand that MTH1 is an important target for cancer [14, 15, 37], whereas on the other hand some studies claim MTH1 inhibition to be nontoxic, thereby questioning the anticancer therapeutic potential of MTH1i [38, 39]. Here, NUDT1 is linked to cancer.